{
  "docId": "019dd923-5f69-752d-a9b9-7febd653c093",
  "docSlug": "ZFP1QxeNpCfFhbrzYAWi",
  "documentTitle": "See the 18-slide pitch deck a genetics startup used to raise $100 million and explore the 'dark side' of the genome",
  "authorId": "Pitchdecks",
  "authorName": "CAMP4",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.778,
  "pageNumber": 14,
  "pageCount": 18,
  "prevPage": 13,
  "nextPage": 15,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 12,
  "notes": "Data source: Hsiao et al, eBiomedicine, 2016",
  "elementsJson": [
    "headline_text",
    "action_title",
    "callout_box",
    "line_chart",
    "line_chart",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5f69-752d-a9b9-7febd653c093/14",
  "deckHref": "/decks/019dd923-5f69-752d-a9b9-7febd653c093",
  "deckJsonHref": "/decks/019dd923-5f69-752d-a9b9-7febd653c093.json",
  "deckAnchorHref": "/decks/019dd923-5f69-752d-a9b9-7febd653c093#slide-14",
  "components": [
    {
      "bbox": {
        "h": 0.11,
        "w": 0.916,
        "x": 0.042,
        "y": 0.145
      },
      "kind": "callout",
      "text": "25% increase in Scn1a mRNA leads to >70% reduction in seizure frequency",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ae9f2929-d633-45ff-8bb7-bf3229f19e2c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.35,
        "x": 0.216,
        "y": 0.338
      },
      "kind": "chart",
      "text": "Scn1a mRNA upregulation",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0b689cec-927c-429f-b233-8c4ab37ec4fc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.35,
        "x": 0.55,
        "y": 0.338
      },
      "kind": "chart",
      "text": "Seizure frequency",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d95717f9-8259-47b8-8fdb-16224ec13fe8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "seizure frequency: >70%",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-abe4-75dc-a303-39b9f5d40fdf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "Hsiao et al, eBiomedicine, 2016",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd952-abe4-75dc-a303-34532e72ca0a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.15,
        "x": 0.057,
        "y": 0.93
      },
      "kind": "source-note",
      "text": "Hsiao et al, eBiomedicine, 2016",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "198e8e48-42ee-4412-97f1-137781450811",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.402,
        "x": 0.026,
        "y": 0.05
      },
      "kind": "title",
      "text": "A mouse analog of CMP-SCN-001 reduces seizures in the Dravet mouse model",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "31b55f11-e2bb-4563-897d-9f1b7e0b13ff",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 18,
      "from": 13,
      "beatId": "83232633-6fc0-4a1b-a0a5-fe516b3d8578",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution (Provide relief)",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "The deck presents CAMP4's approach to Dravet and the potential solution offered by their RAP (p13-18)",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 16,
      "from": 12,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "ad824c9f-ade3-46dc-85b3-9835f23c9a9a",
      "evidence": "The deck presents the market opportunity for CAMP4's targeted SCN1A upregulation approach (p16)",
      "position": 0,
      "objective": "Highlight the cost of inaction for Dravet Syndrome patients",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}